Argenx
ARGX
#575
Rank
โ‚น3.008 T
Marketcap
โ‚น50,320
Share price
0.65%
Change (1 day)
23.42%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Cash on Hand

Cash on Hand as of June 2024 : โ‚น262.08 Billion

According to Argenx 's latest financial reports the company has โ‚น262.08 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Argenx - Cash on Hand chart (from 2021 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚น181.43 B4.32%
2021-12-31โ‚น173.92 B-3.15%
2020-12-31โ‚น179.58 B49.81%
2019-12-31โ‚น119.87 B132.06%
2018-12-31โ‚น51.65 B56.22%
2017-12-31โ‚น33.06 B354.76%
2016-12-31โ‚น7.27 B116.25%
2015-12-31โ‚น3.36 B-35.91%
2014-12-31โ‚น5.24 B91.78%
2013-12-31โ‚น2.73 B73.31%
2012-12-31โ‚น1.57 B-24.7%
2011-12-31โ‚น2.09 B234.93%
2010-12-31โ‚น0.62 B